
The Cuban Center for State Control of Medicines, Equipment and Medical Devices is evaluating for its registration a drug called NeuroEpo, an innovative product against Alzheimer's disease.
Read more Cuba has a drug against Alzheimer's
The University of Holguín opened its doors for the restart of teaching activities corresponding to the 2024 academic year, which concludes on September 27.
Read more Teaching activities begin at the University of Holguín
The Cuban Center for State Control of Medicines, Equipment and Medical Devices approved the phase I/II clinical trial to evaluate the safety and immunogenicity of the vaccine candidate Mambisa -intranasal- and the Abdala vaccine -intramuscular-, a study to boost immunity in convalescents of COVID-19.
Read more Cuba approves clinical trial with Mambisa and Abdala in COVID-19 convalescents
Page 402 of 498